In an effort to boost sales of Optison, Amersham Health has begun a new promotional campaign and is focusing on educational efforts aimed at expanding awareness and use of the echocardiography agent. The new campaign follows on the heels Mallinckrodt's
In an effort to boost sales of Optison, Amersham Health has begun a new promotional campaign and is focusing on educational efforts aimed at expanding awareness and use of the echocardiography agent. The new campaign follows on the heels Mallinckrodt's recent decision to terminate comarketing rights with Amersham regarding Optison.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.